This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Episalvan
  • /
  • NCT01807650 Oleogel-S10 in Wound Healing of Skin G...
Clinical trial

NCT01807650 Oleogel-S10 in Wound Healing of Skin Graft Donor Sites (BSG-12)

Read time: 1 mins
Last updated:1st Mar 2013

The main purpose of this phase III clinical trial is to show safety and efficacy of Oleogel-S10 in the acceleration of Split-Thickness Skin Graft Donor Sites.


Study Type: Interventional
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Standard of Care in Accelerating the Wound Healing of Split Thickness Skin Graft Donor Sites
Enrollment: 112
Study Start Date: March 2013
Study Completion Date: September 2014
Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)

Arms:
- Experimental:
Oleogel-S10
- Non Adhesive wound dressing

Category Value
Study start date 2013-03-01

View full details